BELLUSCURA PLC LS -01 Market Cap ($3.55 Million)
Market Cap & Net Worth: BELLUSCURA PLC LS -01 (9VQ)
BELLUSCURA PLC LS -01 market cap. BELLUSCURA PLC LS -01 (F:9VQ) has a market capitalization of $3.55 Million (€3.04 Million) as of November 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #29180 globally and #2520 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BELLUSCURA PLC LS -01's stock price €0.01 by its total outstanding shares 401309607 (401.31 Million).
BELLUSCURA PLC LS -01 Market Cap History (2021–2025)
BELLUSCURA PLC LS -01 market cap history from 2021 to 2025. Data shows change from $591.16 Million to $3.75 Million (-65.76% CAGR). Check 9VQ stock price and chart for real-time trading data and today's change.
BELLUSCURA PLC LS -01 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BELLUSCURA PLC LS -01's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 9VQ by Market Capitalization
Companies near BELLUSCURA PLC LS -01 in the global market cap rankings as of November 3, 2026.
Key companies related to BELLUSCURA PLC LS -01 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $184.67 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #215 globally with a market cap of $111.95 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $184.67 Billion | $106.20 |
| #215 | Stryker Corporation | NYSE:SYK | $111.95 Billion | $291.86 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $96.54 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of BELLUSCURA PLC LS -01 (2021–2025)
Market capitalization of BELLUSCURA PLC LS -01 from 2021 to today. Between 2021 and today, BELLUSCURA PLC LS -01's market cap moved from $591.16 Million to $ 3.75 Million, with a yearly change of -65.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €3.75 Million | -92.00% |
| 2024 | €46.92 Million | -56.14% |
| 2023 | €106.97 Million | -68.98% |
| 2022 | €344.84 Million | -41.67% |
| 2021 | €591.16 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 29th, 2026 the market cap of BELLUSCURA PLC LS -01 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.55 Million USD |
| MoneyControl | $3.55 Million USD |
| MarketWatch | $3.55 Million USD |
| marketcap.company | $3.55 Million USD |
| Reuters | $3.55 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About BELLUSCURA PLC LS -01
Belluscura plc develops and commercialize oxygen related medical device products in the United States. The company offers X-PLOR and DISCOV-R, a modular portable oxygen concentrator; and related accessories. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.